Hunter C Crose, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 401 W Pennsylvania Ave, Anaconda, MT 59711 Phone: 406-563-8500 Fax: 406-563-8694 |
Dr. Matthew T Graf, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 W Pennsylvania Ave, Anaconda, MT 59711 Phone: 406-563-8686 Fax: 406-563-8691 |
William Zachow, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1102 E Commercial Ave, Anaconda, MT 59711 Phone: 602-790-4221 |
Dr. Adam S Reiss, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 401 W Pennsylvania St, Anaconda, MT 59711 Phone: 406-563-8686 Fax: 406-563-8665 |
Dr. Annie O. Morrison, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 305 W Pennsylvania Ave, Anaconda, MT 59711 Phone: 406-563-8686 |
Roger Pafford, M.D. Family Medicine - Adult Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 W Pennsylvania Ave, Anaconda, MT 59711 Phone: 406-563-8686 Fax: 406-563-8691 |
James G Hueftle, MD Family Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 305 W Pennsylvania Ave, Anaconda, MT 59711 Phone: 406-563-8610 Fax: 406-563-8626 |
Kira A. Conn, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 W Pennsylvania Ave, Anaconda, MT 59711 Phone: 406-563-7282 Fax: 406-563-7243 |
News Archive
"Uncertainty" was a word used repeatedly Monday by Colorado economists and industries in lamenting the failure of the congressional super committee ... Health care is another area with super committee consequences, resulting "in millions of dollars in reduced Medicare payments to Colorado providers for many years to come" by restricting access, Steven Summer, president of the Colorado Hospital Association, said in a statement.
Amyotrophic lateral sclerosis (ALS), characterized by harm to brain neurons and to the spinal cord, also affects the tissue of the retina, according to a study headed up by Universidad Complutense de Madrid.
Onyx Pharmaceuticals, Inc. today reported its financial results for the full year and fourth quarter 2011. Onyx reported non-GAAP net income of $42.0 million, or $0.66 per diluted share, for the full year 2011 compared to non-GAAP net income of $39.2 million, or $0.63 per diluted share, for the same period in 2010.
Machine learning can accurately predict cardiovascular disease and guide treatment-but models that incorporate social determinants of health better capture risk and outcomes for diverse groups, finds a new study by researchers at New York University's School of Global Public Health and Tandon School of Engineering.
› Verified 9 days ago